help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2006-0970
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmer, J. S.
Right arrow Articles by Montgomery, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmer, J. S.
Right arrow Articles by Montgomery, G. W.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 11 4713-4716
Copyright © 2006 by The Endocrine Society


BRIEF REPORT

Novel Variants in Growth Differentiation Factor 9 in Mothers of Dizygotic Twins

James S. Palmer, Zhen Zhen Zhao, Chantal Hoekstra, Nicholas K. Hayward, Penelope M. Webb, David C. Whiteman, Nicholas G. Martin, Dorret I. Boomsma, David L. Duffy and Grant W. Montgomery

Molecular Epidemiology (J.S.P., Z.Z.Z., G.W.M.), Genetic Epidemiology (N.G.M., D.L.D.), Cancer Genetics (N.K.H.), and Cancer and Population Studies (P.M.W., D.C.W.) Laboratories, Queensland Institute of Medical Research, Brisbane 4029, Australia; and Psychology Department (C.H., D.I.B.), Free University, Amsterdam 1081 BT, The Netherlands

Address all correspondence and requests for reprints to: Dr. Grant Montgomery, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, QLD 4029, Australia. E-mail: grant.montgomery{at}qimr.edu.au.


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Context: Genes from the ovarian bone morphogenetic signaling pathway (GDF9 and BMP15) are critical for normal human fertility. We previously identified a deletion mutation in GDF9 in sisters with spontaneous dizygotic (DZ) twins, but the prevalence of rare GDF9 variants in twinning families is unknown.

Objective: The objective was to evaluate the frequency of rare variants in GDF9 in families with a history of DZ twinning.

Design and Subjects: We recruited 3450 individuals from 915 DZ twinning families (1693 mothers of twins) and 1512 controls of Caucasian origin. One mother of DZ twins was selected from 279 of the 915 families, and a DNA sample was screened for rare variants in GDF9 using denaturant HPLC. Variants were confirmed by DNA sequencing and genotyped in the entire sample by matrix-assisted laser desorption ionization time of flight (MALDI-TOF) mass spectrometry.

Results: We found two novel insertion/deletions (c.392-393insT, c.1268-1269delAA) and four missense alterations in the GDF9 sequence in mothers of twins. Two of the missense variants (c.307C>T, p.Pro103Ser and c.362C>T, p.Thr121Leu) were located in the pro-region of GDF9 and two (c.1121C>T, p.Pro374Leu and c.1360C>T, p.Arg454Cys) in the mature protein region. For each variant, the frequencies were higher in cases compared with controls. The proportion of mothers of DZ twins carrying any variant (4.12%) was significantly higher (P < 0.0001) than the proportion of carriers in controls (2.29%).

Conclusion: We describe new variants in the GDF9 gene that are significantly more common in mothers of DZ twins than controls, suggesting that rare GDF9 variants contribute to the likelihood of DZ twinning.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
VARIATION IN DIZYGOTIC (DZ) twinning has a genetic component (1, 2, 3) with family studies showing significantly higher frequencies of DZ twins in female relatives of mothers of DZ twins compared with mothers of monozygotic (MZ) twins (2, 3). Women with a history of DZ twinning have an increased incidence of multiple follicle growth (4, 5), and in other mammals, members of the TGFß superfamily, growth differentiation factor-9 (GDF9), and bone morphogenetic protein-15 (BMP15) play crucial roles in determining follicle growth and ovulation rate (6).

These genes are critical for human fertility. A dominant-negative mutation in BMP15 in Italian sisters resulted in ovarian dysgenesis (7), and rare mutations in both GDF9 and BMP15 contribute to premature ovarian failure (POF) (8, 9, 10). We previously reported a heterozygous loss-of-function mutation in the pro-region of GDF9 in two sisters with spontaneous DZ twins (11), and rare mutations in GDF9 may contribute to an increased frequency of twins in some families. We therefore conducted a screen for GDF9 variants in mothers of spontaneous DZ twins and assessed the frequency of the variants in DZ twinning families.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Study subjects were recruited from 915 families with a history of DZ twinning [755 families from Australia and New Zealand and 160 families from The Netherlands] with 3450 individuals available for genotyping. We recruited families with two or more sisters who gave birth to spontaneous DZ twins (12) and also families with a single case where at least one third-degree female relative had DZ twins. Samples were also obtained from parents of mothers of twins where available and from additional sibs. Mothers of DZ twins and their families were identified through records from our genetic epidemiology studies using twins and their families in Australia (2), through organizations for mothers of twins in Australia and New Zealand, and through appeals in the media in both countries. In The Netherlands, ascertainment was population-based through community records as part of a systematic recruitment to The Netherlands Twin Register (3, 13). Mothers were explicitly asked about fertility treatments, and all such cases were excluded.

Genetic investigation was extended to a population-based control group of 1512 Caucasian individuals (unselected for twinning history). Individuals were selected at random from the electoral role in Australia and enrolled in the study. Study protocols were reviewed and approved by the QIMR Human Research Ethics Committee and the Ethics Committee of the Vrije Universiteit Hospital. Participation was voluntary, and each participant gave written informed consent.

Genetic analysis

The entire coding sequence and intron-exon junctions of the GDF9 gene were analyzed in 279 mothers of DZ twins (one woman from 279 of our 915 sister pair families). Samples were screened by denaturant HPLC of PCR-amplified fragments on a Varian Helix System (Varian, Walnut Creek, CA). Variants were confirmed by DNA sequencing from new PCR products (Applied Biosystems, Foster City, CA).

Assays for all confirmed variants plus two missense mutations c.199A.C (p.Lys67Glu) and c.646G.A (p.Val216Mat) reported by Dixit et al. (9) were designed and genotyped in all study subjects using a compact matrix-assisted laser desorption ionization time of flight (MALDI-TOF) Mass Spectrometer (Sequenom Inc., San Diego). The potential functional significance of missense mutations was predicted using the Align-GVGD program (14) (available at http://agvgd.iarc.fr) with a multiple sequence alignment for mammalian GDF9 protein sequences. Frequency differences were tested by contingency {chi}2 testing with {chi}2 and asymptotic P values estimated, allowing for the family nature of the data as implemented in MENDEL 6.0 (15). To assess the significance of frequency differences between cases and controls, the likelihood for a family containing an individual who was sequenced was corrected by dividing by the likelihood of observing the variant in the discovery phase.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
We identified six new variants within the coding region of GDF9. One mutation (c.1268-1269delAA) resulted in a 2-bp deletion in exon 2 at position 1268. The deletion introduced a frame shift resulting in a premature stop codon 10 amino acids downstream of the deletion and truncation of the mature protein in the putative translation product. A second mutation (c.392-393insT) resulted in a single base insertion in exon 1 at position 393 in the pro-region. The insertion also introduced a frame shift resulting in a premature stop codon at amino acid position 143. We detected four missense alterations in the GDF9 sequence in mothers of twins. Two variants (c.307C>T, p.Pro103Ser and c.362C>T, p.Thr121Leu) were located in the pro-region of GDF9, and two variants (c.1121C>T, p.Pro374Leu and c.1360C>T, p.Arg454Cys) were located in the mature protein region.

We typed five of these variants (c.1268-1269delAA and the missense mutations) in 915 families with a history of DZ twinning including 1693 mothers of DZ twins with genotype data (Table 1Go). The c.1268-1269delAA deletion mutation was detected in two families and in each family was carried by both sisters with DZ twins. One individual carrying the mutation had three sets of DZ twins (Fig. 1Go). The allele frequencies of the five variants were also compared with frequencies in the control group. For each variant, the frequency in cases was greater than the frequency in controls (Table 1Go). The variants c.1268-1269delAA and p.Pro374Leu were not observed in control samples, and the difference between cases and controls was significant for c.1268-1269delAA, p.Pro103Ser, and p.Pro374Leu. Considered together, the frequency of any of the five variants in GDF9 in mothers of twins was twice the frequency in the controls (P = 0.0001). The difference was still significant (P < 0.0026) if only Australia and New Zealand families were compared with controls. The relative risk for carrying a GDF9 variant was 2.15 (95% confidence interval, 1.42–3.24). Because these variants were carried by 2.2% of controls, the attributable risk for twinning due to these five variants was 2.4% (95% confidence interval, 0.9–4.7). No mothers of twins in our sample carried the missense mutations in GDF9 reported in Indian POF patients.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Number of heterozygous carriers (Het) and minor allele frequencies (Freq) of variants identified in GDF9 in 915 DZ twinning families (with 1693 mothers of DZ twins) and in 1512 control samples

 

Figure 1
View larger version (8K):
[in this window]
[in a new window]
 
FIG. 1. Family of sisters with spontaneous DZ twins. Both sisters carry a heterozygous deletion mutation (c.1268-1269delAA) within the coding region of GDF9.

 

    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
GDF9 is an oocyte-derived growth factor essential for follicle growth. We previously reported a heterozygous loss-of- function mutation in GDF9 in two sisters with spontaneous DZ twins (11). We have now identified six additional rare variants in GDF9 in mothers of DZ twins. After ascertainment correction, equivalent to the classic correction of removing the proband variants from the counts for cases before doing the comparison, the frequency of all novel variants was significantly higher in mothers of DZ twins compared with a population-based control group. Frequencies for three individual variants (c.1268-1269delAA, p.Pro103Ser, and p.Pro374Leu) were significantly higher in cases compared with controls.

We observed a low frequency of functional variants within our control group, but this might be expected. Functional variants in GDF9 are unlikely to cause twin ovulations at all cycles, and not all twin ovulations will result in twin pregnancies due to partial failure of such pregnancies ("vanishing twins") (16). The penetrance (defined as the chance of having twins when carrying a functional variant) is expected to be low, as suggested by observations of low concordance rates of female MZ twins giving birth to DZ twins (2). The controls comprised both sexes, and females were unselected with respect to reproductive history.

The significantly higher frequency of GDF9 variants in mothers of twins suggests that some variants may be functional. Two of the novel variants were insertion/deletion mutations that introduce stop codons immediately downstream, increasing the number of truncating mutations in GDF9 observed in sister pairs with spontaneous DZ twins to three (11). The c.1268-1269delAA heterozygous deletion was present in two pairs of sisters with DZ twins. One of the women had three sets of twins, supporting the view that the deletion mutation increases the frequency of twinning. The other women all had a single set of twins as well as other singleton pregnancies, consistent with the expectation that functional variants in genes influencing twinning will have low penetrance. Overall, the increase in twinning frequency is lower than the effect of loss-of-function mutations in GDF9 in sheep (17) and probably reflects species differences in ovulation rate and twinning frequency (6).

The four other novel variants detected were all missense mutations. GDF9, like other members of the TGFß family, is synthesized as a preproprotein. After cleavage of the signal peptide, the GDF9 proprotein forms homodimers and heterodimers with BMP15. Naturally occurring variants in BMP15 and GDF9 affect normal processing of the proprotein dimers (18). Amino acid substitutions are more likely to influence protein function when differences in the biochemical properties are large and the amino acids are located at residues highly conserved between species. Prediction of the likely effects of the mutations (14) suggests that three of the variants (p.Pro103Ser, p.Pro374Leu, and p.Arg454Cys) are important amino acid substitutions at positions conserved in all mammalian GDF9 proteins and are expected to be deleterious. The proline at position 374 and the arginine at position 454 are also conserved in chicken and zebrafish sequences, providing further evidence that these substitutions are likely to have functional consequences. The p.Thr121Leu substitution is also predicted to be deleterious, but with weaker evidence because this amino acid position is not invariant in all mammalian species. Both changes affecting the proline residues were significantly higher in mothers of DZ twins, but not the p.Arg454Cys change.

The demonstration of rare alleles contributing to DZ twinning provides an example of rare variants contributing to a common phenotype. We have previously shown no association between common variation in GDF9 and DZ twinning (11). Recent papers describe rare variants in both GDF9 and BMP15 contributing to POF (7, 8, 9, 10, 19) showing that rare variants in these two genes influence human fertility. The attributable risk for twinning associated with rare variants in GDF9 is small (2.4%), and it is estimated that several hundred similar variants would be required to explain the observed level of familial aggregation for DZ twinning. It is possible that rare variants from other genes in pathways regulating ovarian follicle growth and maturation (including BMP15) also contribute to variation in twinning.

The results also imply a more direct relationship between twinning and POF. Mothers of DZ twins reach menopause significantly earlier than mothers of MZ twins with the difference occurring before age 40 (20). The small increase in the frequency of POF in mothers of DZ twins could be explained by mutations in GDF9 and BMP15 influencing both aspects of ovarian function, although none of our mothers of twins carried the missense mutations reported in Indian POF patients (9). Future studies should examine whether the same variants in GDF9 and BMP15 affect both twinning and POF via common mechanisms or whether different variants affect these two phenotypes.

In conclusion, we identified six novel variants in GDF9 in mothers of DZ twins. Two of the variants were insertion/deletion mutations, with one mutation detected in a woman with three sets of twins. GDF9 gene variants were significantly more prevalent among mothers of DZ twins than controls. Additional studies will be required to determine the effect of these variants on GDF9 function.


    Acknowledgments
 
We thank Kerry King, Barbara Haddon, and Alison MacKenzie for coordination of recruitment and Anjali Henders and Megan Campbell for managing sample preparation. We also thank the Multiple Birth Associations of Australia (AMBA) and New Zealand (NZAMBA) for assistance with recruitment and the mothers of twins and their families for participation in the research.


    Footnotes
 
This work was supported by National Institute of Child Health and Human Development Grant HD042157 and National Health and Medical Research Council of Australia Grants 159100 and 339446 (to G.W.M.).

Disclosure Statement: The authors have nothing to declare.

First Published Online September 5, 2006

Abbreviations: BMP15, Bone morphogenetic protein-15; DZ, dizygotic; GDF9, growth differentiation factor-9; MZ, monozygotic; POF, premature ovarian failure.

Received May 5, 2006.

Accepted August 23, 2006.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Bulmer MG 1970 The biology of twinning in man. Oxford, UK: Oxford University Press
  2. Lewis CM, Healey SC, Martin NG 1996 Genetic contribution to DZ twinning. Am J Med Genet 61:237–246[CrossRef][Medline]
  3. Meulemans WJ, Lewis CM, Boomsma DI, Derom CA, Van den Berghe H, Orlebeke JF, Vlietinck RF, Derom RM 1996 Genetic modelling of dizygotic twinning in pedigrees of spontaneous dizygotic twins. Am J Med Genet 61:258–263[CrossRef][Medline]
  4. Gilfillan CP, Robertson DM, Burger HG, Leoni MA, Hurley VA, Martin NG 1996 The control of ovulation in mothers of dizygotic twins. J Clin Endocrinol Metab 81:1557–1562[Abstract]
  5. Martin NG, Shanley S, Butt K, Osborne J, O’Brien G 1991 Excessive follicular recruitment and growth in mothers of spontaneous dizygotic twins. Acta Genet Med Gemellol (Roma) 40:291–301[Medline]
  6. Moore RK, Erickson GF, Shimasaki S 2004 Are BMP-15 and GDF-9 primary determinants of ovulation quota in mammals? Trends Endocrinol Metab 15:356–361[CrossRef][Medline]
  7. Di Pasquale E, Beck-Peccoz P, Persani L 2004 Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 75:106–111[CrossRef][Medline]
  8. Di Pasquale E, Rossetti R, Marozzi A, Bodega B, Borgato S, Cavallo L, Einaudi S, Radetti G, Russo G, Sacco M, Wasniewska M, Cole T, Beck-Peccoz P, Nelson LM, Persani L 2006 Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 91:1976–1979[Abstract/Free Full Text]
  9. Dixit H, Rao LK, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N, Chakravarty B, Singh L 2005 Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 12:749–754[CrossRef][Medline]
  10. Dixit H, Rao LK, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, Chakrabarty B, Singh L 2006 Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 119:408–415[CrossRef][Medline]
  11. Montgomery GW, Zhao ZZ, Marsh AJ, Mayne R, Treloar SA, James MR, Martin NG, Boomsma DI, Duffy DL 2004 A deletion mutation in GDF9 in sisters with spontaneous DZ twins. Twin Res 7:548–555[CrossRef][Medline]
  12. Montgomery GW, Duffy DL, Hall J, Haddon BR, Kudo M, McGee EA, Palmer JS, Hsueh AJ, Boomsma DI, Martin NG 2000 Dizygotic twinning is not linked to variation at the {alpha}-inhibin locus on human chromosome 2. J Clin Endocrinol Metab 85:3391–3395[Abstract/Free Full Text]
  13. Boomsma DI, Vink JM, van Beijsterveldt TC, de Geus EJ, Beem AL, Mulder EJ, Derks EM, Riese H, Willemsen GA, Bartels M, van den Berg M, Kupper NH, Polderman TJ, Posthuma D, Rietveld MJ, Stubbe JH, Knol LI, Stroet T, van Baal GC 2002 Netherlands Twin Register: a focus on longitudinal research. Twin Res 5:401–406[CrossRef][Medline]
  14. Mathe E, Olivier M, Kato S, Ishioka C, Hainaut P, Tavtigian SV 2006 Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods. Nucleic Acids Res 34:1317–1325[Abstract/Free Full Text]
  15. Lange K, Cantor R, Horvath S, Perola M, Sabatti C, Sinsheimar J, Sobel E 2001 Mendel version 4.0; a complete package for exact genetic analysis of discrete traits in pedigree and population data sets. Am J Hum Genet 69(Suppl):A1886
  16. Landy HJ, Keith LG 1998 The vanishing twin: a review. Hum Reprod Update 4:177–183[Abstract/Free Full Text]
  17. Hanrahan JP, Gregan SM, Mulsant P, Mullen M, Davis GH, Powell R, Galloway SM 2004 Mutations in the genes for oocyte-derived GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod 70:900–909[Abstract/Free Full Text]
  18. Liao WX, Moore RK, Shimasaki S 2004 Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors bone morphogenetic protein-15 and growth and differentiation factor-9. J Biol Chem 279:17391–17396[Abstract/Free Full Text]
  19. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, Aittomaki K, Bourcigaux N, Jacquesson L, Bouchard P, Frydman R, Dewailly D, Reyss AC, Jeffery L, Bachelot A, Massin N, Fellous M, Veitia RA 2006 Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 154:739–744[Abstract/Free Full Text]
  20. Martin NG, Healey SC, Pangan TS, Heath AC, Turner G 1997 Do mothers of dizygotic twins have earlier menopause? A role for fragile X? Am J Med Genet 69:114–116[CrossRef][Medline]



This article has been cited by other articles:


Home page
ReproductionHome page
J. L Juengel, N. L Hudson, M. Berg, K. Hamel, P. Smith, S. B Lawrence, L. Whiting, and K. P McNatty
Effects of active immunization against growth differentiation factor 9 and/or bone morphogenetic protein 15 on ovarian function in cattle
Reproduction, July 1, 2009; 138(1): 107 - 114.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. J. McIntosh, S. Lun, S. Lawrence, A. H. Western, K. P. McNatty, and J. L. Juengel
The Proregion of Mouse BMP15 Regulates the Cooperative Interactions of BMP15 and GDF9
Biol Reprod, November 1, 2008; 79(5): 889 - 896.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Z. Z. Zhao, J. N. Painter, J. S. Palmer, P. M. Webb, N. K. Hayward, D. C. Whiteman, D. I. Boomsma, N. G. Martin, D. L. Duffy, and G. W. Montgomery
Variation in bone morphogenetic protein 15 is not associated with spontaneous human dizygotic twinning
Hum. Reprod., October 1, 2008; 23(10): 2372 - 2379.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
G. W. Montgomery, D. R. Nyholt, Z. Z. Zhao, S. A. Treloar, J. N. Painter, S. A. Missmer, S. H. Kennedy, and K. T. Zondervan
The search for genes contributing to endometriosis risk
Hum. Reprod. Update, September 1, 2008; 14(5): 447 - 457.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
The ESHRE Capri Workshop Group
Genetic aspects of female reproduction
Hum. Reprod. Update, April 2, 2008; (2008) dmn009v1.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
R. B. Gilchrist, M. Lane, and J. G. Thompson
Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality
Hum. Reprod. Update, March 1, 2008; 14(2): 159 - 177.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
C. Hoekstra, Z. Z. Zhao, C. B. Lambalk, G. Willemsen, N. G. Martin, D. I. Boomsma, and G. W. Montgomery
Dizygotic twinning
Hum. Reprod. Update, January 1, 2008; 14(1): 37 - 47.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
Y.-Q. Su, K. Sugiura, K. Wigglesworth, M. J. O'Brien, J. P. Affourtit, S. A. Pangas, M. M. Matzuk, and J. J. Eppig
Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 control cholesterol biosynthesis in cumulus cells
Development, January 1, 2008; 135(1): 111 - 121.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmer, J. S.
Right arrow Articles by Montgomery, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmer, J. S.
Right arrow Articles by Montgomery, G. W.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Female Endocrinology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals